Vigor Medical Technologies

Company Overview

Snapshot

Founded in July 2014 by Irina Kavounovski, John H Abeles MD, and Igor Weisbein, Vigor Medical Technologies operates with 1–10 employees. The company has raised $3.9M across four funding rounds. In December 2024, Vigor Medical Technologies secured equity crowdfunding from ExitValley.

Business overview

Vigor Medical Technologies develops lifesaving devices for treating chest trauma and thoracic/abdominal drainage. Its core product, the C-Lant self-fixation sealing device, is designed to prevent lung and heart collapse. This technology serves emergency medical services, first aid organizations, and hospital departments including ER, trauma, thoracic/abdominal surgery, and pulmonary. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.

Strategic signal

In November 2025, Vigor Medical Technologies was highlighted for its development of an AI-based ultrasound tool for the battlefield. This signals the company's strategic expansion into advanced medical technology, leveraging artificial intelligence to enhance diagnostic capabilities in critical environments, which could significantly impact military and emergency medical applications.

Company Intelligence Q&A

What is Vigor Medical Technologies' primary product?

Vigor Medical Technologies' primary product is the C-Lant self-fixation sealing device, designed to prevent lung and heart collapse following chest trauma.

When was Vigor Medical Technologies founded and by whom?

Vigor Medical Technologies was founded in July 2014 by Irina Kavounovski, John H Abeles MD, and Igor Weisbein.

What was a significant recent funding event for Vigor Medical Technologies?

In December 2024, Vigor Medical Technologies secured equity crowdfunding from ExitValley.

Has Vigor Medical Technologies received any grants?

In December 2022, Vigor Medical Technologies received a grant from the European Innovation Council. The company also received a grant from The Haifa Economic Corporation in May 2019, and from the 1st Innovation Competition of International Talents, Shenzhen China in May 2016.

What is the strategic focus of Vigor Medical Technologies' recent technological advancements?

In November 2025, Vigor Medical Technologies was noted for transforming ultrasound into a smart, AI-based tool for battlefield applications, indicating a strategic focus on integrating artificial intelligence into its medical devices for critical care scenarios.